Jeff Geschwind, MD – Cancer Drug Innovator Founder of Cage Pharma, Jeff Geschwind, MD researches tumor metabolism-targeting drugs, focusing on glycolysis inhibition to disrupt cancer growth, offering new hope for aggressive cancers. https://www.usaveinclinics.com/vein-specialist/jean-francois-geschwind/